跳至主要内容
临床试验/NL-OMON26885
NL-OMON26885尚未招募不适用

Randomized controlled trial to assess the effect of vitamin D plus K supplementation on the rate of elastin degradation in COPD

one0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
one
入组人数
40

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • Diagnosed with COPD based on post-bronchodilator FEV1/FVC <0.70 according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria.
  • Serum 25(OH)D<50 nmol/L
  • Age =40 and =75 years at screening visit

排除标准

  • Subjects using vitamin K as supplements <3 months prior to the screening visit
  • Use of vitamin K antagonists (i.e acenocoumarol, fenprocoumon) in 12 months prior to the screening visit
  • Exacerbation <6 weeks prior to the screening visit
  • Use of digoxin and/or thiazide diuretics
  • Hypercalcemia (i.e. corrected calcium for albumin >2.8 mmol/L)
  • Kidney stones in medical history
  • Severe renal failure (i.e. eGFR < 30 ml/min/1.73 m2)
  • Hyperparathyroidism

研究者

发起方
one

相似试验